Aeterna Zentaris : Reports Fourth Quarter and Full Year 2021

Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook


- Continue to advance and expand opportunities with established... | April 3, 2022

Related Keywords

Germany , Australia , United States , United Kingdom , Massachusetts , Boston , Bulgaria , Canada , Russia , Toronto , Ontario , South Korea , Turkey , Ukraine , Russian , Republic Of Korea , America , Canadian , Lou Gehrig , Jenene Thomas , Thomas Rudel , Joerg Wischhusen , Klaus Paulini , Linkedin , Aeterna Zentaris , Twitter , University Of Queensland , Kim Pharmaceuticals Bulgaria , Nk Meditech Ltd , Nasdaq , Aeterna Zentaris Inc , Vaccine Development Pipeline , European Union , Facebook , Therapeutics Development Pipeline , University Hospital In Wuerzburg , European Commission , University Of Sheffield , University Of Wuerzburg , Toronto Stock Exchange , Diagnostics Development Pipeline , Novo Nordisk , Aeterna Zentaris Reports Fourth Quarter , Full Year , Provides Business , Chief Executive Officer , Julius Maximilians University Wuerzburg , Giuliano La Fratta , Chief Financial , Clinical Programs Update , University Hospital , Michael Levy , Massachusetts General Hospital , Auto Immunity Modifying Biologicals , Clearance Parathyroid Hormone , Fusion Polypeptides , North America , New Drug Application , Er Kim Pharmaceuticals Bulgaria , Vaccine Platform , Fourth Quarter , Financial Statements , Financial Condition , Litigation Reform Act , Novo Amended License Agreement , Annual Report , Aeterna Zentaris Inc Stock Exchange , News , Information , Press Release , Eterna , Centaris , Reports , Fourth , Quarter , End , Bull , Ear , 021 , Financial , Results , Rovides , Business , Ontinue , O , Advance , Xpand , Opportunities , Ith Aezs Ca0079754028 ,